EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Select your location
Local sites
Life Sciences
Our Global Life Sciences sector can help you navigate forward and achieve sustainable success in the new health-outcomes-driven ecosystem.
Aging populations and chronic disease are putting pressure on health resources around the world just as scientific progress, augmented intelligence and digital data are transforming the traditional health care models. This is causing a power shift with new entrants (often not driven by profit) disrupting the incumbents.
Staying competitive and providing the personalized experience that patients demand require life sciences organizations to find new ways of working. Partnering with others to share data, medicine and resources while anticipating trends and regulatory changes will help ensure sustainability in the increasingly evidence-based, outcomes-focused sector.
We help companies across the biotechnology, pharmaceutical and medical technology fields harness this disruption by forming the right alliances, better allocating resources and building trust with customers.
Our Latest thinking
Global transfer pricing controversy for life sciences
In this webcast, panelists discuss global transfer pricing controversy matters for life sciences companies. Register now.
05 Mar 2025 | your local time
Evaluating AI readiness in data, technology and skills
In this webcast, panelists discuss how to effectively navigate the AI landscape. Learn more.
05 Mar 2025 | your local time
How life sciences firms can adapt to trade policies
In this webcast, panelists discuss the impacts of President Trump’s trade agenda on the supply chains of life sciences companies. Learn more.
28 Feb 2025 | your local time
The Unstoppables: Success stories of the world’s most inspiring entrepreneurs
The latest EY entrepreneurship documentary, “The Unstoppables 3,” features inspiring professional and personal entrepreneur success stories. Read more.
09 Apr 2024
Stasia Mitchell
Life sciences dealmaking in a time of change
Life sciences companies are returning to dealmaking amid cost and revenue pressures – how will they find the right deals to secure value? Learn more.
08 Jan 2024
Subin Baral
How will you respond to clinicians sounding the alarm on unsustainable care delivery models?
The EY Global Voices in Health Care Study finds health systems must embrace sustainable care delivery models to address workforce challenges. Learn more.
16 Oct 2023
Kim Dalla Torre
Supply chain visibility strategic priority for pharma
With digitally driven end-to-end supply chain visibility, pharma companies will be better prepared for the next major supply chain disruption. Learn more.
04 Oct 2023
Derron Stark
How digital is changing the tax strategy for MedTech
As MedTech companies make substantial investments in digital technology, there are important tax implications that should be addressed. Learn more.
18 Aug 2023
Ana Maria Romero
Case study: Takeda’s finance transformation with EY teams
In this case study, learn how leading pharmaceutical company Takeda is creating value for patients through finance innovation and process excellence.
14 Aug 2023
Frederik Schmachtenberg
How Takeda harnessed the power of the metaverse for positive human impact
Learn how Takeda harnessed the power of the metaverse for positive human impact.
27 Jun 2023
Edwina Fitzmaurice
Innovation can utilize data for value-based care
Organizations have the tools to deliver a better personalized health experience, but the ecosystem needs to collaborate to build this future. Learn more.
20 Mar 2023
Pamela Spence
Life sciences businesses transform tax and finance
Life sciences organizations operate in a complex industry – one that looks set to become more challenging, including from a tax perspective. Learn more.
07 Mar 2023
EY Global
Why life sciences tax departments need to act now on sustainability
Life sciences organizations should consider tax liabilities and compliance obligations resulting from myriad new sustainability taxes. Learn more.
11 Jan 2023
Rick Fonte
How innovative infostructure can power the purpose of integrated care systems
Sharing organized and complete data to generate insights for better health outcomes is the driving force behind joined-up care in integrated care systems (ICSs).
18 Sep 2022
Erik Vermeulen
How the challenge of regulating AI in healthcare is escalating
Artificial intelligence is forcing healthcare regulators to play catch-up and reimagine the regulation rule book.
27 Jul 2022
Prof. Dr. Heinz-Uwe Dettling
How do you build future supply chains to best serve patient needs?
In the wake of global disruptions, EY research aims to map out the future for supply chain transformation in the pharmaceutical industry. Read more.
18 Jul 2022
Derron Stark
CDMOs are becoming emerging technology leaders
Discover how CDMO M&A trends show CDMOs are becoming emerging technology leaders for pharmaceutical partners.
14 Jul 2022
Dr. Isabelle Heiber
Takeda’s journey through digitalization
Find out how Takeda Business Solutions (TBS) fast-tracked its digitalization evolution.
01 Jul 2022
Helmut Rattenberger
How to navigate global TP controversy in life sciences — Asia-Pacific and Europe focus
In this webcast, panelists discuss life sciences transfer pricing controversy trends and developments in Asia-Pacific and Europe. Learn more.
23 Jun 2022 | your local time
TP controversy in life sciences — US
In this webcast, panelists discuss life sciences transfer pricing controversy trends and developments in the US. Learn more.
22 Jun 2022 | your local time
How EY can help
-
The EY Promotional Content Management Services team can provide you with support that will transform your processes and improve your results. Learn more.
Read more -
The EY Smart Reviewer can help your business accelerate and optimize the review and approval process for marketing and promotional materials. Find out how.
Read more -
Our Biopharma Launch Edge team can help your business achieve successful launches. Find out how.
Read more -
The EY Health Outcomes Platform aligns all stakeholders by providing a practical solution to operate value-based contracts at scale. Find out how.
Read more -
Our Field-force Behavioral Benchmarking team can help your business achieve improved commercial performance. Find out how.
Read more
Direct to your inbox
Stay up to date with our Editor's picks newsletter.